tiprankstipranks
Trending News
More News >
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market

OptimizeRx (OPRX) Financial Statements

Compare
569 Followers

OptimizeRx Financial Overview

OptimizeRx's market cap is currently $226.48M. The company's EPS TTM is $0.2; its P/E ratio is -4,673.08; OptimizeRx is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 92.13M$ 71.52M$ 62.45M$ 61.29M$ 43.31M
Gross Profit$ 59.38M$ 42.90M$ 38.97M$ 35.64M$ 24.11M
Operating Income$ -13.71M$ -26.40M$ -12.29M$ 361.10K$ -2.14M
EBITDA$ -8.90M$ -21.31M$ -9.42M$ 2.33M$ 646.89K
Net Income$ -20.11M$ -17.57M$ -11.44M$ 378.08K$ -2.21M
Balance Sheet
Cash & Short-Term Investments$ 13.38M$ 13.85M$ 74.14M$ 84.68M$ 10.52M
Total Assets$ 171.17M$ 183.37M$ 134.65M$ 140.99M$ 60.33M
Total Debt$ 33.19M$ 36.82M$ 234.43K$ 327.71K$ 448.75K
Net Debt$ 19.81M$ 22.97M$ -17.97M$ -84.35M$ -10.07M
Total Liabilities$ 54.17M$ 56.82M$ 8.54M$ 9.61M$ 10.35M
Stockholders' Equity$ 117.00M$ 126.55M$ 126.11M$ 131.38M$ 49.97M
Cash Flow
Free Cash Flow$ 4.78M$ -8.11M$ 10.41M$ 240.04K$ -6.44M
Operating Cash Flow$ 4.89M$ -7.24M$ 10.65M$ 726.04K$ -6.31M
Investing Cash Flow$ -450.00K$ -25.34M$ -58.18M$ -486.00K$ -124.72K
Financing Cash Flow$ -4.91M$ 28.22M$ -18.95M$ 73.92M$ -1.90M
Currency in USD

OptimizeRx Earnings and Revenue History

OptimizeRx Debt to Assets

OptimizeRx Cash Flow

OptimizeRx Forecast EPS vs Actual EPS